NIH-funded research NIH-funded research

Using viruses to kill harmful bacteria

Official title: Bacteriophage strategies to lyse bacterial cells

Funded at Texas A&m University · NIH-10939083 · Data updated 2026-11-12

This study is exploring how special viruses called bacteriophages can help fight bacterial infections by breaking down the bacteria's outer walls, which could lead to new ways to tackle tough infections that don't respond to antibiotics.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionTexas A&m University
NIH-funded
Lab location1 site (College Station, United States)
Project startSeptember 5, 2024
Project endAugust 31, 2029
Funding year2024
Award (this year)$364,505
NIH project number1R35GM155289-01
Project IDNIH-10939083 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals suffering from bacterial infections, particularly those caused by antibiotic-resistant strains.

Less likely to help

Patients with viral infections or those not affected by bacterial infections may not benefit from this research.

What this research studies

This research investigates how bacteriophages, which are viruses that specifically infect bacteria, can effectively kill bacterial cells. The project focuses on understanding the mechanisms by which these phages release new viral particles by breaking down the bacterial cell walls. By studying the proteins involved in this lysis process, researchers aim to uncover new strategies to combat bacterial infections, particularly those resistant to antibiotics. The approach combines molecular biology techniques with bioinformatics to characterize novel lysis proteins and their functions.

Why it matters

Potential benefit: If successful, this research could lead to new treatments for bacterial infections, especially those that are resistant to current antibiotics.

How similar studies have gone: Previous research has shown promise in using bacteriophages to treat bacterial infections, indicating that this approach has potential for success.

Where this research is happening

  • Texas A&m University
    College Station, United States
    Active

Researchers

  • Principal investigator: Ramsey, Jolene — Texas A&m University
  • Study coordinator: Ramsey, Jolene

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.